NDC 0093-0017
Moexipril Hydrochloride
Moexipril Hydrochloride
Moexipril Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category.  It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Moexipril Hydrochloride.
| Product ID | 0093-0017_47bb5b1f-0ee0-469f-9fcc-fc3087b2e865 | 
| NDC | 0093-0017 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Moexipril Hydrochloride | 
| Generic Name | Moexipril Hydrochloride | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2003-05-08 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA076204 | 
| Labeler Name | Teva Pharmaceuticals USA, Inc. | 
| Substance Name | MOEXIPRIL HYDROCHLORIDE | 
| Active Ingredient Strength | 8 mg/1 | 
| Pharm Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 |